use of antibody drug conjugates and potential for ild
Published 4 years ago • 68 plays • Length 5:59Download video MP4
Download video MP3
Similar videos
-
9:19
rate and class effect of ild with antibody drug conjugates
-
8:18
antibody drug conjugates and interstitial lung disease risk
-
7:10
potential risk of drug-induced interstitial lung disease
-
6:37
educational tools for possible drug-induced ild
-
1:44
what are antibody-drug conjugates and how do they work against cancer?
-
5:50
risks for developing ild and personal experience
-
17:52
how can broadening knowledge in bioconjugate design & development help treat oncology & beyond?
-
7:11
drug-induced ild and rate of occurrence in gi cancer trials
-
2:07
emerging toxicities associated with adcs
-
35:25
antibody drug conjugates and recent applications in breast cancer treatment
-
1:21:32
antibody–drug conjugates for solid tumors: progress, possibilities, and implications for care
-
56:32
antibody drug conjugates for cancer
-
2:28
promising early results of a novel anti-cd123 antibody-drug conjugate in r/r bpdcn
-
57:16
antibody-drug conjugates in the clinic:
-
54:24
model-based strategy to guide the choice of clinical doses for antibody–drug conjugates
-
32:45
advanced characterization of antibody-drug conjugates and antibody-fusion proteins
-
3:23
antibody-drug conjugates in the treatment of solid tumors
-
18:14
in-depth characterization of lysine-conjugated antibody-drug conjugates (adcs) by multiplexed ms/ms
-
7:06
new hope in cancer treatment! what are antibody-drug conjugates (adcs)